The popularity of copyright’s blockbuster initially drove a surge for pharma, but recent developments present a uncertain outlook for shareholders. Off-patent alternatives are eating into revenue, and persistent https://jimipnj819123.life3dblog.com/39640989/viagra-and-big-pharma-a-risky-bet